The clinicopathologic spectrum of segmental membranous glomerulopathy.

Abstract

Membranous glomerulopathy (MGN) is characterized by global subepithelial immune deposits that stain most intensely by immunofluorescence for IgG. Here we describe the clinical and pathologic findings in a cohort of patients with MGN in which, by definition, only segmental immune deposits are present. This rare variant, termed segmental MGN (sMGN), is poorly characterized. We retrospectively identified all patients with sMGN diagnosed at Columbia University from January 2010 to October 2018, excluding those with systemic lupus erythematosus. Data on presenting features, pathologic findings, and outcomes were collected. Fifty cases of sMGN were identified, representing 2.5% of MGN. In 21 of 50 biopsies, there was an alternative, predominant disease process. The remaining 29 patients with isolated sMGN had a median creatinine of 0.97 mg/dl, median 24-hour urine protein 3.1 g/day, and 32% had nephrotic syndrome. Staining for NELL-1 (a protein kinase C binding protein) was positive in five of 17 cases. Staining for PLA2R, THSD7A, and exostosin 1 (autoantigens in primary MGN) was negative in all biopsies evaluated. Ultrastructural evaluation revealed predominantly early stage sMGN (stage 1 or 1-2 in 14/29). Follow-up was available for 21 of the 29 patients with isolated sMGN (median 12 months), including seven who received immunosuppression (primarily glucocorticoids). During follow-up, 86% had stable/improved kidney function and 45% achieved complete while 15% achieved partial remission. Among the 15 patients with isolated sMGN without full nephrotic syndrome, only two received immunosuppression; nonetheless, 50% achieved complete while 21% achieved partial remission. Thus, sMGN is a rare PLA2R-negative variant of MGN with 29% NELL-1 positivity and favorable prognosis, even in the absence of immunosuppressive treatment.

• Authors: Satoru Kudose, Dominick Santoriello, Hanna Debiec, Pietro A Canetta, Andrew S Bomback, M Barry Stokes, Ibrahim Batal, Pierre Ronco, Vivette D D'Agati, Glen S Markowitz
• Journal: Kidney international (Kidney Int) Vol. 99 Issue 1 Pg. 247-255 (01 2021) ISSN: 1523-1755 [Electronic] United States
• PMID: 32599086 (Publication Type: Journal Article)
• Copyright: Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Chemical References

• Immunosuppressive Agents

Topics

• Biopsy
• Glomerulonephritis, Membranous (diagnosis, drug therapy)
• Humans
• Immunosuppressive Agents (therapeutic use)
• Nephrotic Syndrome (diagnosis, drug therapy)
• Retrospective Studies